Strategic Prevention Framework for Prescription Drugs (SPF Rx)
The Strategic Prevention Framework for Prescription Drugs (SPF Rx) grant program provides funds for state agencies that have already completed a Strategic Prevention Framework State Incentive Grant to target prescription drug misuse. Required activities include:
- Raising awareness about the dangers of sharing medications, and work with pharmaceutical and medical communities on the risks of overprescribing to young adults
- Raising community awareness by bringing prescription drug abuse prevention activities and education to schools, communities, parents, prescribers, and their patients
Through this opportunity, SAMHSA will also track reductions in opioid overdoses and the incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans as indicators of the program's success. State applicants must have a fully operational PDMP in order to apply for the SPF Rx program. Tribes must coordinate with the state run PDMPs to identify opportunities for collaboration that will limit overprescribing in tribal communities.
Eligibility is limited to states, U.S. territories, pacific jurisdictions, and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant. Applicants also are required to have an operational state run Prescription Drug Monitoring Program.
Estimated award amount: $371,616 per
year for up to 5 years
Estimated total funding: $9,290,395
Anticipated Number of Awards: 25
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.